ENDLOS-TURBO PUT - AMGEN | Real-time Boerse Frankfurt Warrants 09:34:34 24/05/2024 pm IST | ||
| 9.95 EUR | -0.60% |
|
| Current month | -24.68% | ||
| 1 month | -24.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 9.95 | -0.60% |
| 23/24/23 | 10.01 | +4.93% |
| 22/24/22 | 9.54 | +3.70% |
| 21/24/21 | 9.2 | -1.60% |
| 20/24/20 | 9.35 | -0.64% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 09:34 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ75SD |
| ISIN | DE000DJ75SD8 |
| Date issued | 04/01/2024 |
| Strike | 414.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.57 € |
|---|---|
| Lowest since issue | 8.19 € |
| Spread | 0.02 € |
| Spread % | 0.20% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306.5
USD
Average target price
316.1
USD
Spread / Average Target
+3.12%
- Stock Market
- Certificates
- Certificat
